journal article·2023-10-01Open access

Recent progress of organ-on-a-chip towards cardiovascular diseases: advanced design, fabrication, and applications

Hanbai Wu, Shuo Shi, Yi Liu, Qiang Zhang, Raymond H W Lam, Chwee Teck Lim, Jinlian Hu

Biofabrication· Volume 15· Issue 4

Abstract

Abstract Cardiovascular diseases (CVDs) are a major cause of death worldwide, leading to increased medical care costs. To turn the scale, it is essential to acquire a more in-depth and comprehensive understanding of CVDs and thus formulate more efficient and reliable treatments. Over the last decade, tremendous effort has been made to develop microfluidic systems to recapitulate native cardiovascular environments because of their unique advantages over conventional 2D culture systems and animal models such as high reproductivity, physiological relevance, and good controllability. These novel microfluidic systems could be extensively adopted for natural organ simulation, disease modeling, drug screening, disease diagnosis and therapy. Here, a brief review of the innovative designs of microfluidic devices for CVDs research is presented, with specific discussions on material selection, critical physiological and physical considerations. In addition, we elaborate on various biomedical applications of these microfluidic systems such as blood-vessel-on-a-chip and heart-on-a-chip, which are conducive to the investigation of the underlying mechanisms of CVDs. This review also provides systematic guidance on the construction of next-generation microfluidic systems for the diagnosis and treatment of CVDs. Finally, the challenges and future directions in this field are highlighted and discussed.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Neuroscience and Neural Engineering

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions10.1016/S2214-109X(19)30318-3 ↗
2. Overview of established risk factors for cardiovascular disease
3. Heart disease and stroke statistics—2017 update: a report from the American Heart Association10.1161/CIR.0000000000000485 ↗
4. Notch in mechanotransduction–from molecular mechanosensitivity to tissue mechanostasis10.1242/jcs.250738 ↗
5. Ex vivo models to decipher the molecular mechanisms of genetic notch cardiovascular disorders10.1089/ten.tec.2020.0327 ↗
6. 3D printing of personalized thick and perfusable cardiac patches and hearts10.1002/advs.201900344 ↗
7. Construction of multi-scale vascular chips and modelling of the interaction between tumours and blood vessels10.1039/C9MH01283D ↗
8. 3D bioprinting-tunable small-diameter blood vessels with biomimetic biphasic cell layers10.1021/acsami.0c14871 ↗
9. Microfluidic bioprinting of tough hydrogel-based vascular conduits for functional blood vessels10.1126/sciadv.abq6900 ↗
10. Adaptable microfluidic vessel-on-a-chip platform for investigating tumor metastatic transport in bloodstream10.1021/acs.analchem.2c02556 ↗
11. Engineered human blood–brain barrier microfluidic model for vascular permeability analyses10.1038/s41596-021-00635-w ↗
12. Assembly of tissue-engineered blood vessels with spatially controlled heterogeneities10.1089/ten.tea.2017.0492 ↗
13. A novel strategy for creating tissue-engineered biomimetic blood vessels using 3D bioprinting technology10.3390/ma11091581 ↗
14. Fabrication of PCL/keratin composite scaffolds for vascular tissue engineering with catalytic generation of nitric oxide potential10.1039/D0TB00857E ↗
15. Direct extrusion of individually encapsulated endothelial and smooth muscle cells mimicking blood vessel structures and vascular native cell alignment10.1088/1758-5090/abbd27 ↗
16. Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment10.1016/j.tcm.2017.07.004 ↗
17. MicroRNA and cardiovascular diseases10.4274/balkanmedj.galenos.2020.2020.1.94 ↗
18. Coaxial printing of double-layered and free-standing blood vessel analogues without ultraviolet illumination for high-volume vascularised tissue10.1088/1758-5090/abafc6 ↗
19. Microfluidic technology in vascular research10.1155/2009/823148 ↗
20. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors10.1089/adt.2014.573 ↗
21. The third dimension bridges the gap between cell culture and live tissue10.1038/nrm2236 ↗
22. Methods in cardiomyocyte isolation, culture, and gene transfer10.1016/j.yjmcc.2011.06.012 ↗
23. 3D engineered cardiac tissue models of human heart disease: learning more from our mice10.1016/j.tcm.2012.08.007 ↗
24. Organ chips, organoids and the animal testing conundrum10.1038/s41578-021-00313-z ↗
25. Is it time for reviewer 3 to request human organ chip experiments instead of animal validation studies?10.1002/advs.202002030 ↗
26. The flaws and human harms of animal experimentation10.1017/S0963180115000079 ↗
27. Cardiac spheroids as promising in vitro models to study the human heart microenvironment10.1038/s41598-017-06385-8 ↗
28. Successes and future outlook for microfluidics-based cardiovascular drug discovery. Expert opinion on drug discovery10.1517/17460441.2015.1001736 ↗
29. Technology insight: the evolution of tissue-engineered vascular grafts—from research to clinical practice10.1038/ncpcardio0930 ↗
30. Platelet and endothelial adhesion on fluorosurfactant polymers designed for vascular graft modification10.1002/jbm.a.31888 ↗
31. Small diameter electrospun silk fibroin vascular grafts: mechanical properties, in vitro biodegradability, and in vivo biocompatibility10.1016/j.msec.2015.05.003 ↗
32. Microfluidics in cardiovascular disease research: state of the art and future outlook10.1038/s41378-021-00245-2 ↗
33. Heart-on-a-chip using human iPSC-derived cardiomyocytes with an integrated vascular endothelial layer based on a culture patch as a potential platform for drug evaluation10.1088/1758-5090/ac975d ↗
34. Nanozyme: an emerging alternative to natural enzyme for biosensing and immunoassay10.1016/j.trac.2018.05.012 ↗
35. Sperm-hybrid micromotor for targeted drug delivery10.1021/acsnano.7b06398 ↗
36. Challenges in using circulating micro-RNAs as biomarkers for cardiovascular diseases10.3390/ijms21020561 ↗
37. A review of biosensor technologies for blood biomarkers toward monitoring cardiovascular diseases at the point-of-care10.1016/j.bios.2020.112621 ↗
38. Flow-enhanced electrochemical immunosensors on centrifugal microfluidic platforms10.1039/c3lc50374g ↗
39. Graphene-gated biochip for the detection of cardiac marker Troponin I10.1016/j.aca.2013.11.047 ↗
40. Towards engineering heart tissues from bioprinted cardiac spheroids10.1088/1758-5090/ac14ca ↗
41. Application of the nano-drug delivery system in treatment of cardiovascular diseases10.3389/fbioe.2019.00489 ↗
42. Microfluidic formation of single cell array for parallel analysis of Ca2+ release-activated Ca2+ (CRAC) channel activation and inhibition10.1016/j.ab.2009.09.018 ↗
43. Microfluidics for cell-based high throughput screening platforms—a review10.1016/j.aca.2015.11.023 ↗
44. Production of monodisperse polyurea microcapsules using microfluidics10.1038/s41598-019-54512-4 ↗
45. Recent advances of microneedles for biomedical applications: drug delivery and beyond10.1016/j.apsb.2019.03.007 ↗
46. Microfluidics for core–shell drug carrier particles–a review10.1039/D0RA08607J ↗
47. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy10.1161/01.CIR.99.16.2192 ↗
48. Role of pyroptosis in cardiovascular diseases and its therapeutic implications10.7150/ijbs.33568 ↗
49. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease10.1038/s41569-021-00644-y ↗
50. PDMS with designer functionalities—properties, modifications strategies, and applications10.1016/j.progpolymsci.2018.06.001 ↗
51. Inner surface design of functional microchannels for microscale flow control10.1002/smll.201905318 ↗
52. Human induced pluripotent stem cell-derived arteries as personalized models of atherosclerosis on-a-chip10.1101/2020.11.27.401034 ↗
53. An innovative solvent-responsive coiling–expanding stent10.1002/adma.202101005 ↗
54. Direct-ink written shape-morphing film with rapid and programmable multimotion10.1002/admt.201900974 ↗
55. Cellulose/Chitosan composite multifilament fibers with two-switch shape memory performance10.1021/acssuschemeng.8b06691 ↗
56. Shape memory-enhanced electrical self-healing of stretchable electrodes10.3390/app8030392 ↗
57. The present and future role of microfluidics in biomedical research10.1038/nature13118 ↗
58. Microfluidic-mediated nano-drug delivery systems: from fundamentals to fabrication for advanced therapeutic applications10.1039/D0NR02397C ↗
59. Microfluidics in vascular biology research: a critical review for engineers, biologists, and clinicians10.1039/D2LC00352J ↗
60. A blood vessel model constructed from collagen and cultured vascular cells10.1126/science.2934816 ↗
62. Fabrication of vascularized tissue constructs under chemically defined culture conditions10.1088/1758-5090/aba0c2 ↗
63. Rapid prototyping of microfluidic systems in poly(dimethylsiloxane)10.1021/ac980656z ↗
64. Cellular micropatterns on biocompatible materials10.1021/bp980037b ↗
65. Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip10.1039/c1lc20557a ↗
66. In vitro microvessels for the study of angiogenesis and thrombosis10.1073/pnas.1201240109 ↗
67. A 3D microfluidic platform incorporating methacrylated gelatin hydrogels to study physiological cardiovascular cell–cell interactions10.1039/c3lc00051f ↗
68. Microfluidic technologies for vasculature biomimicry10.1039/C9AN00421A ↗
69. Engineered 3D vascular and neuronal networks in a microfluidic platform10.1038/s41598-018-23512-1 ↗
70. Microfabrication of angiochip, a biodegradable polymer scaffold with microfluidic vasculature10.1038/s41596-018-0015-8 ↗
71. A novel 3D vascular assay for evaluating angiogenesis across porous membranes10.1016/j.biomaterials.2020.120592 ↗
72. Advances in organ-on-a-chip engineering10.1038/s41578-018-0034-7 ↗
73. The origins and the future of microfluidics10.1038/nature05058 ↗
74. Hemodynamic analysis for stenosis microfluidic model of thrombosis with refined computational fluid dynamics simulation10.1038/s41598-021-86310-2 ↗
75. Computational fluid dynamics simulations at micro-scale stenosis for microfluidic thrombosis model characterization10.32604/mcb.2021.012598 ↗
76. Engineering a living cardiac pump on a chip using high-precision fabrication10.1126/sciadv.abm3791 ↗
77. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation10.1038/nm.1955 ↗
78. Structural and hydrodynamic simulation of an acute stenosis-dependent thrombosis model in mice10.1016/j.jbiomech.2011.02.006 ↗
79. Microfluidic systems for modeling human development10.1242/dev.199463 ↗
80. Three-dimensional architecture of cardiomyocytes and connective tissue in human heart revealed by scanning electron microscopy10.1161/CIRCULATIONAHA.110.979815 ↗
81. Recapitulating maladaptive, multiscale remodeling of failing myocardium on a chip10.1073/pnas.1304913110 ↗
82. Heart-on-chip for combined cellular dynamics measurements and computational modeling towards clinical applications10.1007/s10439-022-02902-7 ↗
83. Accordion-like honeycombs for tissue engineering of cardiac anisotropy10.1038/nmat2316 ↗
84. Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip10.1016/j.biomaterials.2016.09.003 ↗
85. Human iPSC-based cardiac microphysiological system for drug screening applications10.1038/srep08883 ↗
86. I-wire heart-on-a-chip II: biomechanical analysis of contractile, three-dimensional cardiomyocyte tissue constructs10.1016/j.actbio.2016.11.010 ↗
87. Sensors in heart-on-a-chip: a review on recent progress10.1016/j.talanta.2020.121269 ↗
88. Electrical assisted patterning of cardiac myocytes with controlled macroscopic anisotropy using a microfluidic dielectrophoresis chip10.1016/j.sna.2006.06.071 ↗
89. Human iPSC-derived myocardium-on-chip with capillary-like flow for personalized medicine10.1063/1.4978468 ↗
90. Engineering of functional, perfusable 3D microvascular networks on a chip10.1039/c3lc41320a ↗
91. Multilayer microfluidic platform for the study of luminal, transmural, and interstitial flow10.1088/1758-5090/ac48e5 ↗
92. Vascularized organoids on a chip: strategies for engineering organoids with functional vasculature10.1039/D0LC01186J ↗
93. Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues10.1039/C5LC01356A ↗
94. Microfluidic and organ-on-a-chip approaches to investigate cellular and microenvironmental contributions to cardiovascular function and pathology10.3389/fbioe.2021.624435 ↗
95. Controlled electromechanical cell stimulation on-a-chip10.1038/srep11800 ↗
96. Non-swelling hydrogel-based microfluidic chips10.1039/C9LC00564A ↗
97. Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases10.1093/cvr/cvab088 ↗
98. Microfluidics-based biomaterials and biodevices10.1002/adma.201805033 ↗
99. Reducing the damage of Ox-LDL/LOX-1 pathway to vascular endothelial barrier can inhibit atherosclerosis10.1155/2022/7541411 ↗
100. Permeability of the endothelial barrier: identifying and reconciling controversies10.1016/j.molmed.2020.11.006 ↗